Signaturefd, LLC Akebia Therapeutics, Inc. Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.72 - $2.93 $583 - $2,376	-811 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$2.26 - $3.34 $3,145 - $4,649	-1,392 Reduced 63.19%	811 $2,000
Q3 2021 Oct 28, 2021	BUY	$2.35 - $3.88 $1,593 - $2,630	678 Added 44.46%	2,203 $6,000
Q2 2021 Jul 26, 2021	BUY	$2.83 - $4.2 $3,118 - $4,628	1,102 Added 260.52%	1,525 $6,000
Q4 2020 Feb 11, 2021	BUY	$2.22 - $3.78 $64 - $109	29 Added 7.36%	423 $1,000
Q3 2020 Nov 03, 2020	BUY	$2.39 - $13.08 $941 - $5,153	394 New	394 $1,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.